An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatme (Q46466769)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatme |
scientific article published in July 2008 |
Statements
1 reference
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatme (English)
1 reference
1 reference
Cesare Gridelli
1 reference
Charles Butts
1 reference
Ronald Feld
1 reference
Ciro Gallo
1 reference
Francesco Perrone
1 reference
1 July 2008
1 reference
1 reference
9
1 reference
4
1 reference
235-238
1 reference